119 related articles for article (PubMed ID: 2366332)
1. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
[TBL] [Abstract][Full Text] [Related]
2. [Control of interstitial pneumonia with the application of immune transfer].
Otsuka M; Mori T
Rinsho Ketsueki; 1990 May; 31(5):584-8. PubMed ID: 2168493
[TBL] [Abstract][Full Text] [Related]
3. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
4. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
Geha RS
J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
[TBL] [Abstract][Full Text] [Related]
5. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
Munoz JL; Insel RA
J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
[TBL] [Abstract][Full Text] [Related]
6. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
Shiobara S; Lum LG; Witherspoon RP; Storb R
Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
[TBL] [Abstract][Full Text] [Related]
8. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
9. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
Jahn S; Kiessig ST; Grunow R; von Baehr R
Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
[TBL] [Abstract][Full Text] [Related]
10. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
Geha RS
J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation.
Teeuwsen VJ; Logtenberg T; Siebelink KH; Lange JM; Goudsmit J; Uytdehaag FG; Osterhaus AD
J Immunol; 1987 Nov; 139(9):2929-35. PubMed ID: 3499462
[TBL] [Abstract][Full Text] [Related]
12. Humoral immunodeficiency in patients after bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Mauz-Körholz C; Zintl F; Burdach S
Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
[TBL] [Abstract][Full Text] [Related]
14. The humoral immune response after thermal injury: an experimental model.
Molloy RG; Nestor M; Collins KH; Holzheimer RG; Mannick JA; Rodrick ML
Surgery; 1994 Mar; 115(3):341-8. PubMed ID: 8128358
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
16. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
Kodo H; Gale RP; Saxon A
J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
Stevens RH; Saxon A
J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
[TBL] [Abstract][Full Text] [Related]
18. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients.
Vavassori M; Maccario R; Moretta A; Comoli P; Wack A; Locatelli F; Lanzavecchia A; Maserati E; Dellabona P; Casorati G; Montagna D
J Immunol; 1996 Dec; 157(12):5739-47. PubMed ID: 8955228
[TBL] [Abstract][Full Text] [Related]
19. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
Parkkali T; Olander RM; Ruutu T; Vuontela K; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1997 May; 19(9):933-8. PubMed ID: 9156269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]